Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder
2018 ◽
Vol 24
(3)
◽
pp. S41-S42
◽
2017 ◽
Vol 107
(5)
◽
pp. 596-603
◽
Keyword(s):
Keyword(s):
2000 ◽
Vol 182
(3)
◽
pp. 937-940
◽
Keyword(s):
2012 ◽
Vol 27
(7)
◽
pp. 2971-2979
◽
2021 ◽
Vol 40
(4)
◽
pp. S67
2013 ◽
Vol 173
(12)
◽
pp. 1615-1618
◽